Abstract
Introduction: Prescription opioid abuse may have adverse dental effects that are irreversible, leaving younger populations with substantially decayed dentitions. This article explores the damaging effects of three years of prescription opioid abuse to a twenty-six-year-old’s dentition and oral health.
Case Presentation: A twenty-six-year-old Caucasian male presented to the University of Pennsylvania School of Dental Medicine with a past medical history of Percocet® abuse. He was consuming approximately twenty tablets per day for three years, and he had neglected to visit a dentist for over five years before arriving to the School of Dental Medicine. Management and Outcome: Intraoral examination revealed gross generalized decay along with generalized plaque accumulation. He was diagnosed with severe plaque induced gingivitis with localized chronic periodontitis and xerostomia. The dental treatment for this patient included periodontal maintenance and control, caries excavation, root canal therapy, extractions of non-restorable teeth, and continuous dental education. Discussion: Prescription opioids are addictive, have high abuse potential, and dentists contribute to this problem by overprescribing these drugs.Keywords: Dental caries, dental management, drug abuse, hydrocodone, oxycodone, opioid, prescription.
Current Drug Safety
Title:Prescription Opioid Abuse and its Potential Role in Gross Dental Decay
Volume: 12 Issue: 1
Author(s): Andrew D. Fraser, Boshi Zhang, Hassan Khan, Henry Ma and Elliot V. Hersh
Affiliation:
Keywords: Dental caries, dental management, drug abuse, hydrocodone, oxycodone, opioid, prescription.
Abstract: Introduction: Prescription opioid abuse may have adverse dental effects that are irreversible, leaving younger populations with substantially decayed dentitions. This article explores the damaging effects of three years of prescription opioid abuse to a twenty-six-year-old’s dentition and oral health.
Case Presentation: A twenty-six-year-old Caucasian male presented to the University of Pennsylvania School of Dental Medicine with a past medical history of Percocet® abuse. He was consuming approximately twenty tablets per day for three years, and he had neglected to visit a dentist for over five years before arriving to the School of Dental Medicine. Management and Outcome: Intraoral examination revealed gross generalized decay along with generalized plaque accumulation. He was diagnosed with severe plaque induced gingivitis with localized chronic periodontitis and xerostomia. The dental treatment for this patient included periodontal maintenance and control, caries excavation, root canal therapy, extractions of non-restorable teeth, and continuous dental education. Discussion: Prescription opioids are addictive, have high abuse potential, and dentists contribute to this problem by overprescribing these drugs.Export Options
About this article
Cite this article as:
Fraser D. Andrew, Zhang Boshi, Khan Hassan, Ma Henry and Hersh V. Elliot, Prescription Opioid Abuse and its Potential Role in Gross Dental Decay, Current Drug Safety 2017; 12 (1) . https://dx.doi.org/10.2174/1574886311666160803111401
DOI https://dx.doi.org/10.2174/1574886311666160803111401 |
Print ISSN 1574-8863 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3911 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Patent Annotations
Recent Patents on CNS Drug Discovery (Discontinued) Candidate Gene Analysis of the Price Foundation Anorexia Nervosa Affected Relative Pair Dataset
Current Drug Targets - CNS & Neurological Disorders mTOR Inhibitors: Facing New Challenges Ahead
Current Medicinal Chemistry Biological Insight, High-Throughput Datasets and the Nature of Neuro-Degenerative Disorders
Current Drug Metabolism Revisiting the Medical Management of Parkinson’s Disease: Levodopa versus Dopamine Agonist
Current Neuropharmacology Commentary (Research Highlights)
CNS & Neurological Disorders - Drug Targets Patent Selections
Recent Patents on Chemical Engineering Coenzyme Q10 and Neurological Diseases: An Update
Letters in Drug Design & Discovery Striving for a Fuller Characterization of the Cellular Neuropathology of Depression Subtypes
Current Psychiatry Reviews Utility of the Electrocardiogram in Drug Overdose and Poisoning: Theoretical Considerations and Clinical Implications
Current Cardiology Reviews Targeting Platinum Resistant Disease in Ovarian Cancer
Current Medicinal Chemistry The Impact of Small Heat Shock Proteins (HspBs) in Alzheimer’s and Other Neurological Diseases
Current Pharmaceutical Design Difficulty with Uncertainty: How It Presents in Eating Disorders and What We Can Do About it
Adolescent Psychiatry Emerging Role of Antioxidants in the Protection of Uveitis Complications
Current Medicinal Chemistry Editorial [Hot Topic: Computational Approaches in Medicinal Chemistry and Drug Discovery (Guest Editor: Dr. Fredy Sussman)]
Current Topics in Medicinal Chemistry Changes of Gene Expression in the Developing Brain by Acute Ethanol Exposure
Current Psychopharmacology Study on the Development of a Cyclohexane Based Tripodal Molecular Device as "OFF-ON-OFF" pH Sensor and Fluorescent Iron Sensor
Current Analytical Chemistry Editorial [Hot Topic:New Approaches for the Treatment of Pain and Inflammation (Guest Editor: Kaustav Biswas)]
Current Topics in Medicinal Chemistry Meloxicam-loaded Phospholipid/solutol® HS15 Based Mixed Nanomicelles: Preparation, Characterization, and in vitro Antioxidant Activity
Pharmaceutical Nanotechnology Ultra-micronized Palmitoylethanolamide Effects on Sleep-wake Rhythm and Neuropathic Pain Phenotypes in Patients with Carpal Tunnel Syndrome: An Open-label, Randomized Controlled Study
CNS & Neurological Disorders - Drug Targets